One of the world’s oldest and deadliest diseases — remains a critically important public health and biomedical research challenge. Despite remarkable advances in reducing malaria incidence and deaths since 2000, recent progress has become stagnant and has even reversed in some regions.
The National Institute of Allergy and Infectious Diseases (NIAID) in the United States is supporting the development of products to control mosquitoes without the limitations of traditional chemical pesticides.
National Institute of Allergy and Infectious Diseases (NIAID) scientists are developing promising dengue virus vaccine candidates, with the goal of creating a vaccine that is protective against all four dengue virus serotypes. Preclinical and early phase clinical testing has been… Read More ›
Zika virus infection among pregnant women can lead to developmental problems in fetuses and newborns.